Aug 14 (Reuters) - Leap Therapeutics Inc LPTX.O:
LEAP THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
LEAP THERAPEUTICS INC - IMPLEMENTS 75% WORKFORCE REDUCTION
LEAP THERAPEUTICS INC: TOTAL COSTS RELATED TO THIS REDUCTION IN FORCE, INCLUDING SEVERANCE PAYMENTS, ARE ESTIMATED TO BE ABOUT $4.5 MILLION
LEAP THERAPEUTICS INC: MAJORITY OF THESE COSTS WILL BE RECOGNIZED IN THIRD AND FOURTH QUARTERS OF 2025
Source text: ID:nPn5zGXTda
Further company coverage: LPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.